Vanderbilt head and neck symptom survey version 2.0: Report of the development and initial testing of a subscale for assessment of oral health

Head and Neck

Volumn 34, Issue 6, 2012, Pages 797-804

  Cooperstein, Emily ^a   Gilbert, Jill ^b   Epstein, Joel B ^c   Dietrich, Mary S ^d,e   Bond, Stewart M ^e   Ridner, Sheila H ^e   Wells, Nancy ^e   Cmelak, Anthony ^b   Murphy, Barbara A ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

dental; head and neck cancer; oral health; patient outcomes; swallowing; toxicities

Indexed keywords

ADULT; AGED; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT TOOL; DENTAL HEALTH; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CANCER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; VALIDATION STUDY; VANDERBILT HEAD AND NECK SYMPTOM SURVEY; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; DISEASE SEVERITY; EATING; HEALTH; MOUTH MUCOSA; MUCOSA INFLAMMATION; MUCOSAL SENSITIVITY; MUCUS; NOTE; NUTRITION; PREVALENCE; RANGE OF MOTION; SPEECH; SWALLOWING; TASTE DISORDER; VANDERBILT HEAD AND NECK SYMPTOM SURVEY VERSION 2.0; XEROSTOMIA;

APPETITE; CHEMORADIOTHERAPY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEGLUTITION DISORDERS; DENTIN SENSITIVITY; DENTURES; FEMALE; HEAD AND NECK NEOPLASMS; HEARING DISORDERS; HUMANS; JAW; MALE; MIDDLE AGED; MOVEMENT; MUCOSITIS; MUCUS; NECK; OLFACTION DISORDERS; ORAL HEALTH; PAIN; QUESTIONNAIRES; RADIOTHERAPY; RANGE OF MOTION, ARTICULAR; SEVERITY OF ILLNESS INDEX; SHOULDER JOINT; SPEECH DISORDERS; TOOTH INJURIES; VOICE DISORDERS; WEIGHT LOSS; XEROSTOMIA;

EID: 84861337931     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21816     Document Type: Review

References (27)

1. Murphy, Gilbert J, Cmelak A, Ridner S,. Symptom control issues and supportive care of patients with head and neck cancers. Clin Adv Hematol Oncol 2007; 5: 807-822.
2. Murphy BA, Gilbert J, Ridner SH,. Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther 2007; 7: 1043-1053.
3. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury pathogenesis, measurement, epidemiology, and consequences for patients. Cancer Suppl 2004; 100: 1995-2025.
4. Brosky ME,. The role of saliva in oral health: strategies for prevention and management of xerostomia. J Support Oncol 2007; 5: 215-225.
5. Bomeli SR, Desai SC, Johnson JT, Walvekar RR,. Management of salivary flow in head and neck patients. Oral Oncol 2008; 44: 1000-1008.
6. Dijkstra PU, Kalk W, Roodenburg JLN,. Trismus in head and neck oncology: a systematic review. Oral Oncol 2004; 40: 879-889.
7. Murphy BA,. Late treatment effects: reframing the question. Lancet Oncol 2009; 10: 530-531.
8. Bentzen SM, Trotti A,. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 2007; 25: 4096-4103.
9. Mandel JS,. Screening for colon and rectal cancer. Cancer Control 1996; 3: 170-177.
10. Epstein JB, Gorsky M, Cabay RJ, et al. Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians. Can Fam Physician 2008; 54: 870-875.
11. Arroll B, Khin N, Kerse N,. Screening for depression in primary care with two verbally asked questions: cross sectional study. Br Med J 2003; 327: 1144-1146.
12. Colpe LJ, Epstein JF, Barker PR, Gfoerer JC,. Screening for serious mental illness in the National Survey on Drug Use and Health (NSDUH). Ann Epidemiol 2009; 19: 210-211.
13. Murphy BA, Dietrich MS, Wells N, et al. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck 2010; 31: 26-37.
14. Rothwell B,. Prevention and treatment of the orofacial complications of radiotherapy. J Am Dent Assoc 1987; 114: 316-322.
15. Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP,. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003; 14: 199-212.
16. Epstein JB, Emerton S, Kolbinson DA, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999; 21: 1-11.
17. Grushka M, Epstein JB, Gorsky M,. Burning mouth syndrome. Am Fam Physician 2002; 65: 615-620.
18. Barker KE, Savage NW,. Burning mouth syndrome: an update of recent findings. Australian Dent J 2005; 50: 220-223.
19. Cerchiari DP, de Moricz RD, Sanjar FA, Rapoport PB, Moretti G, Guerra MM,. Burning mouth pain: etiology. Braz J Otorhinolaryngol 2006; 72: 419-423.
20. Grinspan D, Fernández Blanco G, Allevato MA, Stengel FM,. Burning mouth syndrome. Int J Derm 1995; 34: 483-487.
21. Klasser GD, Fischer DJ, Epstein JB,. Burning mouth syndrome: recognition. Oral Maxillofacial Surg Clin N Am 2008; 20: 255-271.
22. Logan HL, Bartoshuk LM, Fillingim RB, Tomar SL, Mendenhall WM,. Metallic taste phantom predicts oral pain among 5-year survivors of head and neck cancer. Pain 2008; 140: 323-331.
23. Sreebny LM,. Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140-161.
24. Sreebny LM,. Recognition and treatment of salivary induced conditions. Int Dent J 1989; 39: 197-204.
25. Meraw SJ, Reeve CM,. Dental considerations and treatment of the oncology patient receiving radiation therapy. J Am Dent Assoc 1998; 129: 201-205.
26. Dijkstra PU, Huisman PM, Roodenburg JLN,. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006; 35: 337-342.
27. Kent ML, Brennan MT, Noll JL, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 2008; 16: 305-309.